ISSN: ISSN 2472-0429

Avances en la prevención del cáncer

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Anti-virus {virus COVID-19}: Yes! Were used to Resolve it as a Cancer Problem. It Works for Ebola

Winston Vo

When viruses infect host cells or organs, the dysfunction of these parts (or tumors) is a result. We name it “a tumor” then we tackle it as a cancer issue! Very straightforward: it works for Ebola.

We have options in oncology: Surgery, Radiation, Chemotherapy, and Immunotherapy. Depending on the rate of its spread, we use one or a combination of those treatments. The rate of success depends on the stage (spread of tumors).

Infection with COVID-19 often causes a severe acute respiratory syndrome. We could consider it as a lung cancer, and treatment plans for it are already well-established in the field of oncology. It’s a virus, so the patient should be considered a candidate for treatment with immunotherapy (or vaccines) based on our body’s defense against cancer.